🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Easy to understand talk with excellent synthesis. Kudos Vedang Murthy from Tata Memorial Hospital luisajacomina Edward Christopher "Chris" Dee, MD Michelle Ann B. Eala, MD 🇵🇭 Melvin LK CHUA | FRCR, PhD, FASCO Kevin Chua

Cisplatin still king in fit patients Important to properly select patients who are not cisplatin candidates But does avelumab really improve outcomes? (p=0.059) Important work nonetheless at #ESMO2024 in #hncsm Glad to see #radonc papers in #medonc meetings

Excellent work by my colleague Warren Bacorro from University of Santo Tomas and the GEC ESTRO on HN #radonc #brachytherapy

Need a more robust discussion to redefine patient selection for MDT as this is now a moving target. C. Jillian Tsai, MD, PhD Shankar Siva Melvin LK CHUA | FRCR, PhD, FASCO Vedang Murthy Kevin Chua

Kudos to NRG Oncology HN team led by Quynh Thu Le and Sue Yom for publishing HN004. Need to identify better treatment options for curable cisplatin ineligible #hncsm patients

👏👏👏

My brilliant med student asked me to explain correlation, causation, confounding &collider bias. I used the following ex… so sharing here in case anyone finds it helpful! PS -I have learned much from David Nunan CEBM Catalogue of Bias - a great resource for EBM. hopefully he approves😅

Brilliant explanations below 👇

Fantastic summary of MDT trials and directions in OMBC! Key question to our #bcsm #radonc #sbrt folks: DOES an oligometastatic state exist in breast cancer? luisajacomina Wendy Woodward MDPhD Simona F. Shaitelman MD, EdM C. Jillian Tsai, MD, PhD David Palma, MD, PhD

The UST Faculty of Medicine & Surgery and #Philippine #Dental Association #oral #oncology seminar series 🇵🇭 Dr @MikeMejiaMD's introduction to HN #radiation ☢️ fostering #multidisciplinary collaboration with over 200 #dental 🦷 #medical ⚕️ and allied attendees from all over the Philippines 🙏

#hncsm #npc It’s time to have that conversation of reducing toxicity for select patients. Volume reduction may be one avenue to achieve this the more we know about the behavior of the disease Warren Bacorro luisajacomina Edward Christopher "Chris" Dee, MD

Grateful to Dr @LuisaJacomina and our entire team Dr @MikeMejiaMD, Dr Cherry Estilo, Dr Gelo Militante, Dr Ian Fernando, and Dr Sandy Uy for promoting #oral #oncology #education in the #Philippines 🇵🇭 Some tough cases today needing true multidisciplinary collaboration! 🤝

Expanding the role of SABR in #headandneckcancer is always both challenging and exciting. Kudos to GORTEC

Future directions in #hncsm is #SBRT. Not new in NPC as it was part of our reRT cohort (ascopubs.org/doi/10.1200/JG…), but it may be time to increase breadth and depth

First of 2 consensus statements coming out for #NPC. This one is an effort undertaken with most of the participants from #LMIC settings. Excellent inclusivity effort from Warren Bacorro and team. kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

We’re honored to have our work featured by ASTRO! What started as a determined effort in resource-limited settings has grown into something we’re truly proud of. We hope to bridge important knowledge gaps in the understanding and management of #NPC Warren Bacorro Melvin LK CHUA | FRCR, PhD, FASCO

Regional nodal irradiation in negative nodal status and after primary systemic therapy - amazing teaching lecture by Philip Poortmans and Liesbeth Boersma #ESTRO25 #radonc #breastcancer OncoAlert #OncoAlert

Questions hopefully answered

Still of the conviction that most #nasopharyngealcarcinoma is best treated by upfront CCRT so would’ve been an outlier vote here. ACT with cape or GP for high risk.

What a #Legend He was one of the few who always kept it FUN and REAL and left a lasting impression when I first heard him speak at ASTRO Annual Meeting Alan Dal Pra, MD Alejandro (Ale) Berlin Daniel E Spratt Vedang Murthy Sean McBride Kevin Chua Michael Mejia Shankar Siva